Social isolation significantly increases the risk of mortality in patients with chronic obstructive pulmonary disease (COPD), ...

Patients with locally advanced hepatocellular carcinoma (HCC) who achieve a complete response after locoregional therapy and ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

This multiyear follow-up of more than 3300 patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) who ...

Panelists express their gratitude for the informative discussion and share their final thoughts on the evolving landscape of ...

On Friday, President-elect Donald Trump announced his nominations to lead the CDC, for FDA Commissioner, and for Surgeon ...

The US has not gotten a grade above a C+ since 2013, as the preterm birth rate has gone up almost a whole percentage point in ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...

The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had the greatest impact on ...

A claims-based study revealed high adherence to phosphorodiamidate morpholino oligomer (PMO) treatments for Duchenne muscular dystrophy (DMD), but highlights limitations in interpreting real-world ...

A presentation at the National Community Pharmacists Association Annual Meeting and Exposition focused on the latest on COVID ...